Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
4.640USD
+0.680+17.17%
Close 11-12 16:00（ET）
10.49MMarket Cap
LossP/E TTM
Collplant Biotechnologies Ltd (CLGN) Stock Price Target & Forecast
Target Price
11.000USD+3556.91%
CLGN Analyst Recommendation Trends
In the current month, CLGN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLGN average Analyst price target in the last month is 11.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
CLGN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, CLGN EPS is projected to reach -0.200 in FY2026Q3, following reported EPS of -1.890 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.90
-0.19
0.35
-0.20
-0.16
Actual
-2.51
-2.25
-1.89
--
--
Surprise
-32.01%
-1085.68%
-639.89%
--
--
FAQs
What is Collplant Biotechnologies Ltd's expected revenue for the next quarter?
Collplant Biotechnologies Ltd's expected revenue is 1.20M.
What is Collplant Biotechnologies Ltd's price target?
Analysts forecast that Collplant Biotechnologies Ltd's price target is USD 11.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 11.00.
How have Collplant Biotechnologies LtdCLGN's recent earnings per share performed?
The market expectation was USD -1.89, while Collplant Biotechnologies LtdCLGN's earnings per share (EPS) for the previous quarter was USD -2.25. EPS for the next quarter is expected at USD -0.20.